FindTrial
Sign In

Observational study of Clinical Characteristics and outcome of snakebite patients at a tertiary care center in Purvanchal, India

Clinical profile and outcome of snake envenomation in patients presenting to tertiary care center of Purvanchal,India- An observational study. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104092
Enrollment
30
Registered
2026-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T630- Toxic effect of snake venom

Interventions

Intervention1: Nil: Nil

Sponsors

Sir Sunderlal Hospital, IMS,BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Confirmed or suspected history of snakebite. 2)Patients with clinical signs and symptoms of envenomation. 3)Admitted to emergency department and Intensive Care Unit. 4)Received or considered for anti-snake venom therapy

Exclusion criteria

Exclusion criteria: 1)Dry bites. 2)Age less than 18 years and more than 65years 3)Unknown bite source or cases.

Design outcomes

Primary

MeasureTime frame
To assess the clinical profile and outcomes of patients with snake envenomation admitted to tertiary care center of Purvanchal, India.Timepoint: To assess the clinical profile and outcomes of patients presenting with snake envenomation from admission (baseline),1week,2week,3week, 4week further till discharge—

Secondary

MeasureTime frame
1)Determine demographic characteristics. 2)classify type of envenomation. 3)Evaluate complications associated with snake envenomation. Timepoint: Assesing from admission(baseline) to 1week,2week,3week,4week further till discharge of participants.—

Countries

India

Contacts

Public ContactDr Vandana

IMS,BHU

Vandanasingh39270@gmail.com8987415191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026